Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.15
-0.85 (-1.85%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Spruce Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -51.35 | -38.97 | -53.04 | -47.92 | -46.18 | -42.29 |
Depreciation & Amortization | 0.89 | 0.02 | 0.05 | 0.07 | 0.07 | 0.07 |
Loss (Gain) From Sale of Assets | - | - | 0 | 0 | 0.04 | - |
Loss (Gain) From Sale of Investments | - | - | - | -0.64 | 0.02 | 0.12 |
Stock-Based Compensation | 3.67 | 2.57 | 5.35 | 4.62 | 3.63 | 3.96 |
Other Operating Activities | 3.88 | 3.77 | 0.25 | 0.23 | -0.4 | 0.31 |
Change in Accounts Payable | 0.4 | -0.35 | -2.04 | 1.91 | -1.4 | -0.81 |
Change in Unearned Revenue | - | - | -4.91 | 4.91 | - | - |
Change in Other Net Operating Assets | -0.11 | -0.37 | -1.62 | 3.54 | 2.53 | 2.76 |
Operating Cash Flow | -42.62 | -33.33 | -55.96 | -33.28 | -41.68 | -35.88 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.15 | - | - | -0.01 | -0.01 | -0.09 |
Investment in Securities | - | - | - | 55.78 | 23.7 | -79.08 |
Investing Cash Flow | -0.15 | - | - | 55.78 | 23.69 | -79.17 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 5 |
Long-Term Debt Repaid | - | -2.06 | -1.62 | -1.62 | - | -4.77 |
Net Debt Issued (Repaid) | 12.9 | -2.06 | -1.62 | -1.62 | - | 0.23 |
Issuance of Common Stock | 119.07 | 50.07 | 0.25 | 53.79 | 0.08 | 0.46 |
Repurchase of Common Stock | -0.84 | -0.83 | -0.25 | -0.31 | -0.04 | - |
Other Financing Activities | -8.45 | -3.7 | - | -2.72 | -0.28 | -0.05 |
Financing Cash Flow | 122.68 | 43.48 | -1.62 | 49.14 | -0.24 | 0.64 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 79.91 | 10.15 | -57.59 | 71.64 | -18.23 | -114.4 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -42.77 | -33.33 | -55.96 | -33.28 | -41.69 | -35.97 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -1139.56% | -329.88% | - | - |
Free Cash Flow Per Share | -30.02 | -43.47 | -101.73 | -64.82 | -132.90 | -115.48 |
Levered Free Cash Flow | -20.65 | -16.67 | -38.75 | -17.52 | -25.55 | -20.7 |
Unlevered Free Cash Flow | -19.53 | -16.61 | -38.56 | -17.22 | -25.28 | -20.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.07 | 0.07 | 0.23 | 0.37 | 0.27 | 0.21 |
Change in Working Capital | 0.3 | -0.72 | -8.57 | 10.36 | 1.13 | 1.96 |